Last reviewed · How we verify
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
The purpose of this study is to investigate the success rate of a switch from insulin therapy to a metformin \& saxagliptin combination in patients with type 2 diabetes mellitus.
Details
| Lead sponsor | ikfe-CRO GmbH |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 120 |
| Start date | 2010-02 |
| Completion | 2011-02 |
Conditions
- Diabetes Mellitus, Type 2
Interventions
- Metformin and Saxagliptin
Primary outcomes
- percentage of patients with stable HbA1c — 26 ± 2 weeks (baseline to postbaseline values) at 4 week intervals
Countries
Germany